Novo Nordisk Invest 4 A/S — Credit Rating and Financial Key Figures

CVR number: 31853923
Novo Alle 1, 2880 Bagsværd
tel: 44448888

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Other operating income49.00
Gross profit-60.00-6.00-53.00-55.00
Costs of management-72.00-60.00-55.00-53.00-55.00
EBIT-72.00- 120.00-12.00- 106.00- 110.00
Other financial income2.0011.0060.0063.00
Other financial expenses-53.00-1.00
Pre-tax profit- 123.00-61.005.007.008.00
Income taxes15.0024.00-1.00-2.00-1.00
Net earnings- 108.00-37.004.005.007.00

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current amounts owed by group member comp.1 821.001 845.00
Current owed by particip. interest comp.2 235.002 184.001 977.00
Current deferred tax assets41.0045.00
Short term receivables total2 276.002 229.001 977.001 821.001 845.00
Balance sheet total (assets)2 276.002 229.001 977.001 821.001 845.00

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital1 000.001 000.001 000.001 000.001 000.00
Retained earnings924.00816.00779.00783.00788.00
Profit of the financial year- 108.00-37.004.005.007.00
Shareholders equity total1 816.001 779.001 783.001 788.001 795.00
Non-current liabilities total
Current owed to participating410.00425.00151.00
Short-term deferred tax liabilities12.001.003.002.00
Other non-interest bearing current liabilities38.0025.0042.0030.0048.00
Current liabilities total460.00450.00194.0033.0050.00
Balance sheet total (liabilities)2 276.002 229.001 977.001 821.001 845.00
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.